Nvidia Earnings Call in Focus Market Watches for Commentary on China Chip Restrictions and Geopolitical Tensions Alphabet Hosts Q1 2026 Earnings Call Investors Eye Cloud and AI Growth Microsofts GitHub Faces Reliability and Competitive Headwinds in AI Coding Race Micron Milestone Dicks Earnings and Paxtons Primary Win Lead CNBC Morning Squawk Federal Cannabis Rescheduling Could Lift Tax Burden Potentially Unlocking Billions for Industry Consumer Sentiment Hits Record Low in May as Rising Gas Prices from Iran Conflict Weigh on Outlook Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment SWBI Q1 2026 Earnings Earnings Beat Expectations Amid Revenue Uncertainty Alexanders Inc ALX Q1 2026 Earnings Solid EPS Performance Amid Limited Disclosures FGNXP Q1 2026 Earnings Massive EPS Surprise on OneTime Gains BioVie Inc Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Development OCS Q1 2026 Earnings WiderthanExpected Loss Weighs on Stock Lockheed Martin LMT Climbs 14 as Defense Sector Finds Support SunCar Technology SDA Surges 139 VolumeDriven Breakout Attempt Above Key Resistance AbCellera Biologics ABCL Surges 53 as Biotech Sentiment Improves Social Commerce Partners SCPQ Consolidates Near Key Support Potential Breakout or Breakdown Ahead Mueller Water Products MWA Edges Lower Amid Consolidation Near Key Levels Hindalco Expects Strong FY26 Performance Novelis Turnaround Anticipated by FY27 MD Satish Pai NAGE Q1 2026 Earnings EPS Beats Estimates by a Slim Margin Stock Declines Lixte Biotechnology LIXT Slides 525 as Stock Tests Key Support at 532 Capital Bancorp Inc CBNK Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Decline PG Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gains TMHC Q1 2026 Earnings EPS Surges Past Estimates by 2856 Stardust Power Inc Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Challenges PubMatic PUBM Q1 2026 Earnings EPS Beats Estimates as AdTech Efficiency Drives Positive Surprise TAL Q1 2026 Earnings Massive EPS Beat Amidst Revenue Uncertainty GSK Q1 2026 Earnings EPS Surprise Beats Estimates Stock Slips Slightly